PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,159,000 | -3.5% | 685,404 | -10.9% | 0.01% | 0.0% |
Q2 2020 | $2,238,000 | +3.2% | 769,198 | 0.0% | 0.01% | -18.2% |
Q1 2020 | $2,169,000 | -13.1% | 769,198 | 0.0% | 0.01% | +22.2% |
Q4 2019 | $2,496,000 | +57.2% | 769,198 | +4.6% | 0.01% | +50.0% |
Q3 2019 | $1,588,000 | +817.9% | 735,100 | +1236.5% | 0.01% | +500.0% |
Q2 2019 | $173,000 | -15.6% | 55,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $205,000 | +28.1% | 55,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $160,000 | +10.3% | 55,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $145,000 | +12.4% | 55,000 | 0.0% | 0.00% | – |
Q2 2018 | $129,000 | -20.4% | 55,000 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $162,000 | +7.3% | 55,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $151,000 | -64.4% | 55,000 | -56.0% | 0.00% | -50.0% |
Q3 2017 | $424,000 | +37.2% | 125,000 | 0.0% | 0.00% | +100.0% |
Q2 2017 | $309,000 | +8.8% | 125,000 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $284,000 | +7.2% | 125,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $265,000 | -36.8% | 125,000 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $419,000 | +6.6% | 125,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $393,000 | -5.5% | 125,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $416,000 | -53.0% | 125,000 | -50.0% | 0.00% | 0.0% |
Q4 2015 | $886,000 | +40.9% | 250,000 | +100.0% | 0.00% | -33.3% |
Q3 2015 | $629,000 | -21.8% | 125,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $804,000 | -8.5% | 125,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $879,000 | -8.8% | 125,000 | 0.0% | 0.00% | -25.0% |
Q4 2014 | $964,000 | +3.2% | 125,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $934,000 | -22.8% | 125,000 | 0.0% | 0.00% | -20.0% |
Q2 2014 | $1,210,000 | – | 125,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |